Spontaneous aggregation and altered intracellular distribution of endogenous α-synuclein during neuronal apoptosis

Antonietta Gentile, Giuseppina Amadoro, Veronica Corsetti, Maria T. Ciotti, AnnaLucia Serafino, Pietro Calissano

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The precursor of the non-amyloid-β component of Alzheimer's disease amyloid (NACP), also known as α-synuclein, is a presynaptic terminal molecule that accumulates in the senile plaques of Alzheimer's disease. Aberrant accumulation of this protein into insoluble aggregates has also been implicated in the pathogenesis of many other neurodegenerative diseases, collectively referred to as synucleinopathies. However, the precise pathogenetic mechanism that leads to aggregate formation and the consequent cellular damage remains elusive. Analyzing differentiated primary cultures of cerebellar granule neurons undergoing apoptosis due to K+ reduction from 25 mM to 5.0 mM, a neuronal model widely used to study event linking apoptosis and neurodegeneration [1], we assessed that endogenous monomeric α-synuclein decreases and spontaneously aggregates into detergent-insoluble high molecular species. Apoptosis is also correlated with a marked redistribution/accumulation of this protein from terminal neurites to perikaria, with formation of compact inclusion bodies in juxta-nuclear area. In addition, secretion of monomeric α-synuclein decreases in response to apoptotic stimulus, while part of it aggregates into fibrillar structures and becomes detectable by immunogold-electron microscope analysis. The data presented in this study demonstrate that an apoptotic event caused by a "physiological" trigger, such as neuronal membrane repolarization of cultured cerebellar granule neurons, induces α-synuclein intracellular redistribution and aggregation, two molecular events reminiscent of those occurring in different human neurodegenerative diseases all characterized by α-synuclein-positive inclusions. Our study indicates this in vitro neuronal system as an excellent model to dissect pathogenic mechanism(s).

Original languageEnglish
Pages (from-to)151-160
Number of pages10
JournalJournal of Alzheimer's Disease
Volume13
Issue number2
Publication statusPublished - 2008

Fingerprint

Synucleins
Apoptosis
Neurodegenerative Diseases
Alzheimer Disease
Neurons
Inclusion Bodies
Amyloid Plaques
Presynaptic Terminals
Neurites
Amyloid
Detergents
Proteins
Electrons
Membranes

Keywords

  • α-synuclein
  • Aggregation
  • Apoptosis
  • CGNs

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Cite this

Spontaneous aggregation and altered intracellular distribution of endogenous α-synuclein during neuronal apoptosis. / Gentile, Antonietta; Amadoro, Giuseppina; Corsetti, Veronica; Ciotti, Maria T.; Serafino, AnnaLucia; Calissano, Pietro.

In: Journal of Alzheimer's Disease, Vol. 13, No. 2, 2008, p. 151-160.

Research output: Contribution to journalArticle

Gentile, A, Amadoro, G, Corsetti, V, Ciotti, MT, Serafino, A & Calissano, P 2008, 'Spontaneous aggregation and altered intracellular distribution of endogenous α-synuclein during neuronal apoptosis', Journal of Alzheimer's Disease, vol. 13, no. 2, pp. 151-160.
Gentile, Antonietta ; Amadoro, Giuseppina ; Corsetti, Veronica ; Ciotti, Maria T. ; Serafino, AnnaLucia ; Calissano, Pietro. / Spontaneous aggregation and altered intracellular distribution of endogenous α-synuclein during neuronal apoptosis. In: Journal of Alzheimer's Disease. 2008 ; Vol. 13, No. 2. pp. 151-160.
@article{6c41fb972836425f8fb5fec3ae134570,
title = "Spontaneous aggregation and altered intracellular distribution of endogenous α-synuclein during neuronal apoptosis",
abstract = "The precursor of the non-amyloid-β component of Alzheimer's disease amyloid (NACP), also known as α-synuclein, is a presynaptic terminal molecule that accumulates in the senile plaques of Alzheimer's disease. Aberrant accumulation of this protein into insoluble aggregates has also been implicated in the pathogenesis of many other neurodegenerative diseases, collectively referred to as synucleinopathies. However, the precise pathogenetic mechanism that leads to aggregate formation and the consequent cellular damage remains elusive. Analyzing differentiated primary cultures of cerebellar granule neurons undergoing apoptosis due to K+ reduction from 25 mM to 5.0 mM, a neuronal model widely used to study event linking apoptosis and neurodegeneration [1], we assessed that endogenous monomeric α-synuclein decreases and spontaneously aggregates into detergent-insoluble high molecular species. Apoptosis is also correlated with a marked redistribution/accumulation of this protein from terminal neurites to perikaria, with formation of compact inclusion bodies in juxta-nuclear area. In addition, secretion of monomeric α-synuclein decreases in response to apoptotic stimulus, while part of it aggregates into fibrillar structures and becomes detectable by immunogold-electron microscope analysis. The data presented in this study demonstrate that an apoptotic event caused by a {"}physiological{"} trigger, such as neuronal membrane repolarization of cultured cerebellar granule neurons, induces α-synuclein intracellular redistribution and aggregation, two molecular events reminiscent of those occurring in different human neurodegenerative diseases all characterized by α-synuclein-positive inclusions. Our study indicates this in vitro neuronal system as an excellent model to dissect pathogenic mechanism(s).",
keywords = "α-synuclein, Aggregation, Apoptosis, CGNs",
author = "Antonietta Gentile and Giuseppina Amadoro and Veronica Corsetti and Ciotti, {Maria T.} and AnnaLucia Serafino and Pietro Calissano",
year = "2008",
language = "English",
volume = "13",
pages = "151--160",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Spontaneous aggregation and altered intracellular distribution of endogenous α-synuclein during neuronal apoptosis

AU - Gentile, Antonietta

AU - Amadoro, Giuseppina

AU - Corsetti, Veronica

AU - Ciotti, Maria T.

AU - Serafino, AnnaLucia

AU - Calissano, Pietro

PY - 2008

Y1 - 2008

N2 - The precursor of the non-amyloid-β component of Alzheimer's disease amyloid (NACP), also known as α-synuclein, is a presynaptic terminal molecule that accumulates in the senile plaques of Alzheimer's disease. Aberrant accumulation of this protein into insoluble aggregates has also been implicated in the pathogenesis of many other neurodegenerative diseases, collectively referred to as synucleinopathies. However, the precise pathogenetic mechanism that leads to aggregate formation and the consequent cellular damage remains elusive. Analyzing differentiated primary cultures of cerebellar granule neurons undergoing apoptosis due to K+ reduction from 25 mM to 5.0 mM, a neuronal model widely used to study event linking apoptosis and neurodegeneration [1], we assessed that endogenous monomeric α-synuclein decreases and spontaneously aggregates into detergent-insoluble high molecular species. Apoptosis is also correlated with a marked redistribution/accumulation of this protein from terminal neurites to perikaria, with formation of compact inclusion bodies in juxta-nuclear area. In addition, secretion of monomeric α-synuclein decreases in response to apoptotic stimulus, while part of it aggregates into fibrillar structures and becomes detectable by immunogold-electron microscope analysis. The data presented in this study demonstrate that an apoptotic event caused by a "physiological" trigger, such as neuronal membrane repolarization of cultured cerebellar granule neurons, induces α-synuclein intracellular redistribution and aggregation, two molecular events reminiscent of those occurring in different human neurodegenerative diseases all characterized by α-synuclein-positive inclusions. Our study indicates this in vitro neuronal system as an excellent model to dissect pathogenic mechanism(s).

AB - The precursor of the non-amyloid-β component of Alzheimer's disease amyloid (NACP), also known as α-synuclein, is a presynaptic terminal molecule that accumulates in the senile plaques of Alzheimer's disease. Aberrant accumulation of this protein into insoluble aggregates has also been implicated in the pathogenesis of many other neurodegenerative diseases, collectively referred to as synucleinopathies. However, the precise pathogenetic mechanism that leads to aggregate formation and the consequent cellular damage remains elusive. Analyzing differentiated primary cultures of cerebellar granule neurons undergoing apoptosis due to K+ reduction from 25 mM to 5.0 mM, a neuronal model widely used to study event linking apoptosis and neurodegeneration [1], we assessed that endogenous monomeric α-synuclein decreases and spontaneously aggregates into detergent-insoluble high molecular species. Apoptosis is also correlated with a marked redistribution/accumulation of this protein from terminal neurites to perikaria, with formation of compact inclusion bodies in juxta-nuclear area. In addition, secretion of monomeric α-synuclein decreases in response to apoptotic stimulus, while part of it aggregates into fibrillar structures and becomes detectable by immunogold-electron microscope analysis. The data presented in this study demonstrate that an apoptotic event caused by a "physiological" trigger, such as neuronal membrane repolarization of cultured cerebellar granule neurons, induces α-synuclein intracellular redistribution and aggregation, two molecular events reminiscent of those occurring in different human neurodegenerative diseases all characterized by α-synuclein-positive inclusions. Our study indicates this in vitro neuronal system as an excellent model to dissect pathogenic mechanism(s).

KW - α-synuclein

KW - Aggregation

KW - Apoptosis

KW - CGNs

UR - http://www.scopus.com/inward/record.url?scp=44849117984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44849117984&partnerID=8YFLogxK

M3 - Article

C2 - 18376057

AN - SCOPUS:44849117984

VL - 13

SP - 151

EP - 160

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -